# COBRE in Digestive & Liver Disease

> **NIH NIH P20** · MEDICAL UNIVERSITY OF SOUTH CAROLINA · 2020 · $2,242,500

## Abstract

Overall – Project Summary
The overall goal of the Center of Biomedical Research Excellence (COBRE) in Digestive & Liver Diseases
(CDLD) is to enable outstanding multidisciplinary collaborative research in digestive and liver diseases at the
Medical University of South Carolina. These diseases are of importance to the state of South Carolina because
of the tremendous, disproportionate burden they have upon the state’s citizens. The specific aims are to: 1)
Mentor, train, recruit and retain a cadre of early career scientists to become independently funded investigators
in digestive and liver diseases research; 2) Develop sustainable scientific core resources to support digestive
and liver disease studies while leveraging institutional investments; and 3) Promote the long-term viability and
success of the CDLD through development of multidisciplinary basic science research programs, rigorous
evaluation, ongoing improvement strategies, and mission alignment with other centers at MUSC. The Center is
led by a multidisciplinary team of two department chairs within the MUSC College of Medicine, coalescing
resources to achieve their overarching objective of building a critical mass of funded investigators that will allow
MUSC to compete for future external peer-reviewed programmatic grant support. This application highlights four
of our most outstanding Junior Investigators (JIs) who will benefit from an innovative multiple source mentoring
plan which features both internal and external mentors. We anticipate each of these JIs to transition to
independent NIH funding within the first three years of the project. The CDLD also includes three Cores that will
support not only the JIs but also digestive and liver disease investigators throughout the medical center.
Scientific cores include the: 1) Cell Models Core, which will generate advanced cell models of digestive and liver
diseases; 2) Animal Models of Digestive Disease Core, which will provide access to and training in essential
animal models; and 3) Advanced Imaging Core, delivering sophisticated equipment, technologies and expertise
required for successful, state-of-the-art cell and tissue-based imaging and analysis. Additionally, the CDLD will
foster collaborations among digestive and liver disease researchers by promoting interdisciplinary scientific
exchange through our enrichment activities and build research capabilities through our Pilot Project Program.
With NIH and institutional support, the CDLD will attain our long-term goal of integratin basic, translational and
clinical research as a sustainable, multidisciplinary, programmatic center.

## Key facts

- **NIH application ID:** 9853384
- **Project number:** 1P20GM130457-01A1
- **Recipient organization:** MEDICAL UNIVERSITY OF SOUTH CAROLINA
- **Principal Investigator:** STEPHEN A DUNCAN
- **Activity code:** P20 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $2,242,500
- **Award type:** 1
- **Project period:** 2020-04-03 → 2025-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9853384

## Citation

> US National Institutes of Health, RePORTER application 9853384, COBRE in Digestive & Liver Disease (1P20GM130457-01A1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9853384. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*